Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronie's Disease
Date:10/11/2010

ients.  XIAFLEX will be administered two times a week every six weeks for up to four treatment cycles (2 x 4).  Each treatment cycle will be followed by a penile modeling procedure.  Patients will be followed for 52 weeks post-first injection in the double-blind studies and for 36 weeks in the open label trial.  

The trials' co-primary endpoints are the change from baseline in the Peyronie's disease bother domain of the Peyronie's Disease Questionnaire (PDQ) compared to placebo and percent improvement from baseline in penile curvature compared to placebo.  The PDQ will have at least three domains, which will include Peyronie's disease bother, severity of psychological and physical symptoms of Peyronie's disease, and penile pain.  Safety measurements will include adverse event monitoring, immunogenicity testing and clinical labs.

"We are encouraged by the clinical profile of XIAFLEX, which emerged from our earlier phase IIb clinical trial in Peyronie's disease.  XIAFLEX was well-tolerated and produced clinically significant reductions in both penile curvature and disease bother," said Dr. Jim Tursi, Auxilium's Vice President of Clinical Research & Development.  "Over the last six months, our team, in conjunction with the U.S. Food and Drug Administration (FDA), outside experts and men with Peyronie's disease, has spent a considerable amount of time and effort to refine the PDQ, which has now been accepted for use in the phase III clinical trials by the FDA's Study Endpoint and Label Development (SEALD) Division."

Conference Call and WebcastAuxilium will hold a webcast and conference call today, October 11, 2010 at 8:30 a.m. ET, to:

  • discuss the initiation of the global phase III program of XIAFLEX for the treatment of Peyronie's disease; and
  • update the leading indicators for the launch of XIAFLEX in Dupuytren's contracture.

  • The presentation slides to be used during the cal
    '/>"/>

    SOURCE Auxilium Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
    3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
    4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    6. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
    7. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
    8. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
    9. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
    10. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
    11. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/27/2015)... , March 27, 2015 ... by Product (Diagnostic Catheter (Conventional, Advanced, Ultrasound), Ablation Catheter ... X-ray)) & Indication (AF, VT, WPW) - Global Forecasts ... is expected to reach around ~$4.73 Billion by 2019 ... period 2014 to 2019. Browse   ...
    (Date:3/27/2015)... 2015  Johnson & Johnson (NYSE: JNJ ) will ... Time) on Thursday, April 23, 2015, from the State Theatre ... Investors and other interested parties may access the live audio ... www.jnj.com and clicking on the webcast icon. ... made available a few hours after the live meeting concludes. ...
    (Date:3/26/2015)... HOUSTON , March 26, 2015  The ... of a study independently conducted by the Department ... Japan have been published. ... compared 5-fluorouracil hepatic arterial infusion as post-operative adjuvant ... colorectal metastasis of the liver. ...
    Breaking Medicine Technology:Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4
    ... Flu Shot Clinics Nationwide, COLUMBIA, Md., Oct. 16 ... flu clinics hosted by Maxim Health Systems.,The company,s Web ... based on user zip codes. "We are in ... too late,to get vaccinated," said Steve Pellito, National Director ...
    ... Iowa, Oct. 16 Protocol Driven Healthcare,Inc. ... a partnership,with Hallmark Insights to provide fully ... of the ConXus health improvement platform. ... services,for reward points earned by participants completing ...
    Cached Medicine Technology:Flu Season Is Here -- Vaccinations Are Still Plentiful 2Flu Season Is Here -- Vaccinations Are Still Plentiful 3PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs 2
    (Date:3/28/2015)... March 28, 2015 With more ... the fields of osteoporosis, osteoarthritis and musculoskeletal diseases ... it may be the first time in the ... forum that the hot-button topic is an emerging ... the well-accepted scientific principles of Wolff’s law, osteogenic ...
    (Date:3/28/2015)... 28, 2015 India Network visitor ... made available to all visitors who purchase the plan ... members are encouraged to purchase the insurance program as ... of proper coverage for pre-existing medical conditions. Parents and ... two medical conditions with serious consequences to their health. ...
    (Date:3/28/2015)... NV (PRWEB) March 28, 2015 One ... re-injury, according to research presented today at the American ... Day. The study examined the long term success of ... , “We examined survey data from 242 patients who ... author Justin P. Roe, MBBS, FRACS, from North Sydney ...
    (Date:3/28/2015)... (PRWEB) March 28, 2015 Genomic medicine ... peritoneal mesothelioma, revealing, for the first time, key information ... here to read the newly posted story on ... the University of British Columbia, the British Columbia Cancer ... mapping to reveal underlying molecular alterations and mutations that ...
    (Date:3/28/2015)... March 28, 2015 Healthpointe’s otolaryngologists, medical ... and throat disorders, are now offering a wide ... issue which is characterized by the presence of phantom ... 5 people, tinnitus is a prevalent symptom that can ... it is non-fatal, tinnitus can impede a person’s quality ...
    Breaking Medicine News(10 mins):Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2
    ... Persistent protein expression may explain why tumors return after ... on March 5th in the Journal of ... the most prevalent malignant brain tumor in adults, includes ... of blood vessels to the tumor. Unfortunately, in most ...
    ... in German . Researchers from the ... cancer cells from chemotherapy -- and they demonstrate which medication ... in the journal Natural Structural and Molecular Biology ... many cancer drugs have already been in use for decades, ...
    ... JACKSONVILLE, Fla. Researchers have identified a gene that causes ... necks twist involuntarily. The discovery by a team from the ... Tennessee Health Sciences Center sheds light on a movement disorder ... the Annals of Neurology . In ...
    ... HealthDay Reporter , FRIDAY, March 2 (HealthDay News) -- Driven ... of their own biology, women are more likely than men ... insomnia much more frequently in women, probably at least 50 ... assistant professor of neurology at the University of Texas Southwestern ...
    ... FRIDAY, March 2 (HealthDay News) -- Preemies face a relatively ... research suggests that the degree to which a child,s health ... child was. Those born between the 32nd and 36th ... issues than those born slightly later in the 37th or ...
    ... and nongovernmental organizations has published a report proposing a ... in asthma clinical research. Asthma Outcomes in Clinical Research: ... a supplement to the March 2012 issue of the ... from a meeting organized by the National Institutes of ...
    Cached Medicine News:Health News:How chemotherapy becomes more effective 2Health News:Researchers ID gene behind primary cervical dystonia, a neck-twisting disorder 2Health News:Researchers ID gene behind primary cervical dystonia, a neck-twisting disorder 3Health News:For Sleep Struggles, Women Urged to Alter Routines 2Health News:For Sleep Struggles, Women Urged to Alter Routines 3Health News:For Sleep Struggles, Women Urged to Alter Routines 4Health News:Timing of Preemie Birth May Be Key to Kids' Health Later 2Health News:Standardized outcome measures proposed for asthma clinical research 2
    ... Terason's background in high performance ... in the field of echocardiography. ... resolution, high frame rates, and sensitive ... Ultrasound System, based upon Terason's proprietary ...
    The Polygraf ID multi-parametric recorder works with POLYGRAM NET analysis software to create a unique interface that combines web-style navigation, graphical presentation and intuitive design to del...
    ... Endoscopic cases, it is extremely popular to combine ... Light. This combination affords the surgeon optimal ... an uncomfortable pose. The Single Light System ... System. As such the light can be ...
    ... DVO-1000MD is the only medical grade DVD recorder ... recorder has two exclusive features DVORECOVERY™ and DVOFAST™, ... friendly recorders ever designed. DVORECOVERY enables the end ... accidental power outage. DVOFAST enables you to remove ...
    Medicine Products: